Type I (insulin-dependent) diabetes is a Th1- and Th2-mediated autoimmune disease

Clinical and Diagnostic Laboratory Immunology

Volumn 6, Issue 3, 1999, Pages 306-310

  Azar, Sami T ^a,b   Tamim, Hala ^c   Beyhum, Hayfa N ^a   Zouhair Habbal, M ^a   Almawi, Wassim Y ^d  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^b Chronic Care Center Hazmieh   (Lebanon)

^c UNIVERSITY OF BALAMAND   (Lebanon)

^d SAINT GEORGE HOSPITAL UNIVERSITY MEDICAL CENTER   (Lebanon)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN SPECIFICITY; AUTOIMMUNE DISEASE; AUTOIMMUNITY; DIABETES MELLITUS; DISEASE PREDISPOSITION; HLA TYPING; IMMUNOMODULATION; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; SHORT SURVEY; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

EID: 0032964001     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.6.3.306-310.1999     Document Type: Short Survey

References (93)

1. Abbas, A. K., K. M. Murphy, and A. Sher. 1996. Functional diversity of helper T lymphocytes. Nature 383:787-793.
2. Anderson, J. T., J. G. Cornelius, A. J. Jarpe, W. E. Winter, and A. B. Peck. 1993. Insulin-dependent diabetes in the NOD mouse model. II. β cell destruction in autoimmune diabetes is a Th2- and not a Th1-mediated event. Autoimmunity 15:113-122.
3. Atkinson, M. A., and N. K. Maclaren. 1994. The pathogenesis of insulin-dependent diabetes mellitus. N. Engl. J. Med. 24:1428-1436.
4. Bach, J. F., and C. Boitard. 1987. Experimental models of type I diabetes. Pathol. Immunopathol. Res. 304:77-78.
5. Balasa, B., and N. Sarvetnick. 1996. The paradoxical effect of interleukin 10 in the immunoregulation of autoimmune diabetes. J. Autoimmun. 9:283-286.
6. Berman, M. A., C. I. Sandborg, Z. Wang, K. L. Imfeld, F. Zaldivar, V. Dadufalza, and B. A. Buckingham. 1996. Decreased IL-4 production in new-onset type I insulin-dependent diabetes mellitus. J. Immunol. 157:4690-4696.
7. Beyers, A. D., L. L. Spruyt, and A. F. Williams. 1992. Molecular associations between the T-lymphocyte antigen receptor complex and the surface antigens CD2, CD4, or CD5. Proc. Natl. Acad. Sci. USA 89:2945-2949.
8. Beyhum, H. N., S. T. Azar, and W. Y. Almawi. 1997. Association of altered T cell immunity with insulin-dependent diabetes mellitus (IDDM). More than a cause and effect. Int. J. Diabetes 5:124-141.
9. Boitard, C., J. Timsit, P. Sempe, and J.-F. Bach. 1991. Experimental immunoprevention of type I diabetes mellitus. Diabetes Metab. Rev. 7:15-33.
10. Calzada-Wack, J. C., M. Frankenberger, and H. W. Ziegler-Heitbrock. 1996. Interleukin-10 drives human monocytes to CD16 positive macrophages. J. Inflamm. 46:78-85.
11. Cameron, M. J., G. A. Arreaza, and T. L. Delovitch. 1997. Cytokine- and costimulation-mediated therapy of IDDM. Crit. Rev. Immunol. 17:537-544.
12. Cantrell, D. 1996. T cell antigen receptor signal transduction pathways. Annu. Rev. Immunol. 14:259-274.
13. Chahine, A. A., M. Yu, M. M. McKernan, C. Stoeckert, and H. T. Lau. 1995. Immunomodulation of pancreatic islet allografts in mice with CTLA-4Ig secreting muscle cells. Transplantation 59:1313-1318.
14. Chen, W., and A. Zlotnick. 1991. IL-10: a novel cytotoxic T cell differentiation factor. J. Immunol. 147:528-534.
15. Cogan, E., L. Schandane, A. Crusiaux, P. Cachaux, T. Velu, and M. Goldman. 1994. A Th2 clonal disease presenting as hypereosinophilic syndrome. N. Engl. J. Med. 330:535-538.
16. Colotta, F., M. Sironi, A. Borre, W. Luini, F. Maddalena, and A. Mantovani. 1992. Interleukin 4 amplifies monocyte chemotactic protein and interleukin 6 production by endothelial cells. Cytokine 4:24-28.
17. Constant, S., C. Pfeifer, A. Woodard, T. Pasqualini, and K. Bottomly. 1996. Extent of T cell receptor ligation can determine the functional differentiation of naive CD4+ T cells. J. Exp. Med. 182:1591-1596.
18. Desai, D. M., M. E. Newton, T. Kadlecek, and A. Weiss. 1990. Stimulation of the phosphatidyl inositol pathway can induce T cell activation. Nature 348: 66-69.
19. DeSilva, D. R., K. B. Urdahl, and M. K. Jerkins. 1991. Clonal anergy is induced in vitro by T cell receptor occupancy in the absence of proliferation. J. Immunol. 147:3261-3267.
20. De Waal-Malefyt, R., H. Yssel, and J. E. De Vries. 1993. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation. J. Immunol. 150:4754-4765.
21. Duncan, D. D., and S. L. Swain. 1994. Role of antigen-presenting cells in the polarized development of helper T cell subsets: evidence for differential cytokine production by Th0 cells in response to antigen presentation by B cells and macrophages. Eur. J. Immunol. 24:2506-2514.
22. Faust, A., H. Rothe, U. Schade, E. Lampeter, and H. Kolb. 1996. Primary nonfunction of islet grafts in autoimmune diabetic nonobese diabetic mice is prevented by treatment with interleukin-4 and interleukin-10. Transplantation 62:648-652.
23. Figueredo, A., J. L. Ibarra, A. Rodriguez, A. M. Molino, E. Gomez-de la Concha, A. Fernandez-Cruz, and R. Patino. 1996. Increased serum levels of IgA antibodies to hsp 70 protein in patients with diabetes mellitus; their relationship with vascular complications. Clin. Immunol. Immunopathol. 79: 252-255.
24. Flodstrrom, M., and D. L. Eizirik. 1997. Interferon gamma-induced interferon regulatory factor-1 (IRF-1) expression in rodent and human islet cells precedes nitric oxide production. Endocrinology 138:2747-2753.
25. Fox, C. J., and J. S. Danska. 1997. IL-4 expression at the onset of islet inflammation predicts nondestructive insulitis in nonobese diabetic mice. J. Immunol. 158:2414-2424.
26. Garcia, K., C. Scott, A. Brunmark, F. Carbone, P. Peterson, I. Wilson, and L. Teyton. 1996. CD8 enhances formation of stable T-cell receptor/MHC class I molecule complexes. Nature 384:577-581.
27. Go, N. F., B. E. Castle, R. Barrett, R. Kastelein, W. Dang, T. R. Mosmann, K. W. Moore, and M. Howard. 1990. Interleukin-10, a novel B cell stimulatory factor. Unresponsiveness of X chromosome-linked immunodeficiency B cells. J. Exp. Med. 172:1525-1531.
28. Hagopian, W. A., B. Michelsen, A. E. Karlsen, F. Larsen, A. Moody, C. E. Grubin, R. Rowe, J. Petersen, R. McEvoy, and A. Lernmark. 1993. Autoantibodies in IDDM primarily recognize the 65,000-Mr rather than the 67,000-Mr isoform of glutamic acid decarboxylase. Diabetes 42:631-636.
29. Hampl, J., T.-H. Chien, and M. M. David. 1997. CD4 augments the response of a T cell to agonist but not to antagonist ligands. Immunity 7:379-385.
30. Hancock, W. W., M. Polanski, J. Zhang, N. Blogg, and H. L. Weiner. 1995. Suppression of insulitis in nonobese diabetic (NOD) mice by oral insulin administration is associated with selective expression of interleukin-4 and -10, transforming growth factor-β, and prostaglandin E. Am. J. Pathol. 147: 1193-1199.
31. Harding, F. A., J. G. McArthur, J. A. Gross, D. Raulett, and J. P. Allison. 1992. CD28-mediated signaling costimulates murine T cells and prevents induction of energy in T cell clones. Nature 356:607-609.
32. Healey, D., P. Ozegbe, S. Arden, P. Chandler, J. Hutton, and A. Cooke. 1995. In vivo and in vitro specificity of CD4+ Th1 and Th2 cells derived from the spleens of diabetic NOD mice. J. Clin. Investig. 95:2979-2985.
33. Heurtier, A. H., and C. Boitard. 1997. T-cell regulation in murine and human autoimmune diabetes: the role of Th1 and Th2 cells. Diabetes Metab. Rev. 23:377-385.
34. Hsieh, C.-S., S. E. Macatonia, C. S. Tripp, S. F. Wolf, A. O'Garra, and K. M. Murphy. 1993. Development of Th1 CD4+ T cells through IL-12 produced by Listeria induced macrophages. Science 260:547-549.
35. Huang, X., J. Uan, A. Goddard, A. Foulis, T. James, A. Lernmark, R. Pujol-Borrell, A. Rabinovitch, N. Somoza, and T. A. Stewart. 1995. Interferon expression in the pancreas of patients with type I diabetes. Diabetes 44: 658-664.
36. Hussain, M. J., M. Peakman, H. Gallati, S. S. S. Lo, M. Hawa, G. C. Viberti, P. J. Watkins, R. D. G. Leslie, and D. Vergani. 1996. Elevated serum levels of macrophage-derived cytokines precede and accompany the onset of IDDM. Diabetologia 39:60-69.
37. Itoh, N., T. Hanafusa, A. Miyazaki, J. Miyagawa, K. Yamagata, K. Yamamoto, M. Waguri, A. Imagawa, S. Tamura, M. Inada, S. Kawata, S. Tarui, N. Kono, and Y. Matsuzawa. 1993. Mononuclear cell infiltration and its relation to the expression of major histocompatibility complex antigens and adhesion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependent diabetes mellitus patients. J. Clin. Investig. 92:2313-2322.
38. Izquierdo Pastor, M., K. Reif, and D. Cantrell. 1995. The regulation and function of p21ras during T-cell activation and growth. Immunol. Today 16: 159-163.
39. Katz, J. D., C. Benoist, and D. Mathis. 1995. T helper cell subsets in insulin-dependent diabetes. Science 268:1185-1188.
40. Kelso, A. 1995. Th1 and Th2 subsets: paradigms lost? Immunol. Today 16: 374-379.
41. Kuchroo, V. K., M. P. Das, J. A. Brown, A. M. Ranger, S. S. Zamvil, R. A. Sobel, H. L. Weiner, N. Nabavi, and L. H. Glimcher. 1995. B7-1 and B7-2 costimulatory molecules differentially activate the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 80:707-718.
42. Kundig, T. M., A. Shahinian, K. Kawai, H. W. Mittrucker, E. Sebzda, M. F. Bachmann, T. W. Mak, and P. S. Ohashi. 1996. Duration of TCR stimulation determines co-stimulatory requirements of T cells. Immunity 5:41-52.
43. Kurrer, M. O., S. V. Pakala, H. L. Hanson, and J. D. Katz. 1992. β cell apoptosis in T cell mediated autoimmune diabetes. Proc. Natl. Acad. Sci. USA 94:213-218.
44. Lee, M.-S., R. Mueller, L. S. Wicker, L. B. Peterson, and N. Sarvetnick. 1996. IL-10 is necessary and sufficient for autoimmune diabetes in conjunction with NOD MHC homozygosity. J. Exp. Med. 183:2663-2668.
45. Lee, M. S., L. S. Wicker, L. B. Peterson, and N. Sarvetnick. 1997. Pancreatic IL-10 induces diabetes in NOD.B6 Idd3 Idd10 mice. Autoimmunity 26:215-221.
46. Lee, M.-S., L. Wogensen, J. Shizuru, M. B. A. Oldstone, and N. Sarvetinick. 1994. Pancreatic islet cell production of murine interleukin-10 does not inhibit immune-mediated tissue destruction. J. Clin. Investig. 93:1332-1338.
47. Lehmann, P. V., E. E. Sercerz, T. Forsthuber, C. M. Dayan, and G. Gammon. 1993. Determinant spreading and the dynamics of the autoimmune T cell repertoire. Immunol. Today 14:203-207.
48. Lenschow, D. J., K. C. Herold, L. Rhee, B. Patel, A. Koons, H. Y. Qin, E. Fuchs, B. Singh, C. B. Thompson, and J. A. Bluestone. 1996. CD28/B7 regulation of Th1 and Th2 subsets in the development of autoimmune diabetes. Immunity 5:285-293.
49. Lichtman, A. H., J. Chin, J. A. Schmidt, and A. K. Abbas. 1988. Role of interleukin 1 in the activation of T lymphocytes. Proc. Natl. Acad. Sci. USA 85:9699-9703.
50. Lindsten, T., C. H. June, J. A. Ledbetter, G. Stella, and C. B. Thompson. 1989. Regulation of lymphokine mRNA stability by a surface-mediated T cell activation pathway. Science 244:339-343.
51. Linsley, P. S., W. Brady, L. Grosmaire, A. Aruffo, N. K. Damle, and J. A. Ledbetter. 1991. Binding of the B cell activation antigen B7 to CD28 co-stimulates T cell proliferation and interleukin 2 mRNA accumulation. J. Exp. Med. 173:721-730.
52. Lipton, R. B., M. Kocova, R. E. LaPorte, J. S. Dorman, T. J. Orchard, W. J. Riley, A. L. Drash, D. J. Becker, and M. Trucco. 1992. Autoimmunity and genetics contribute to the risk of insulin-dependent diabetes mellitus in families: islet cell antibodies and HLA DQ heterodimers. Am. J. Epidemiol. 136:503-512.
53. Liscovitch, M. 1992. Crosstalk among multiple signal-activated phospholipases. Trends Biochem. Sci. 17:393-399.
54. Macatonia, S. E., T. M. Doherty, S. C. Knight, and A. O'Garra. 1993. Differential effect of IL-10 on dentritic cell-induced T cell proliferation and IFN-γ production. J. Immunol. 150:3755-3765.
55. Maggi, E., P. Parronchi, R. Manetti, C. Simonelli, M. Piccinni, F. S. Rugiu, M. De Carli, M. Ricci, and S. Romagnani. 1992. Reciprocal regulatory effect of IFN-γ and IL-4 on the in vitro development of human Th1 and Th2 clones. J. Immunol. 148:2142-2147.
56. Mandrup-Poulsen, T., K. Bendtzen, C. A. Dinarello, and J. Nerup. 1987. Human tumor necrosis factor potentiates human interleukin-1 mediated rat pancreatic beta cell cytotoxicity. J. Immunol. 139:4077-4082.
57. Mandrup-Poulsen, T., F. Pociot, J. Molvig, L. Shapiro, P. Nilsson, T. Emdal, M. Roder, L. L. Kjems, C. A. Dinarello, and J. Nerup. 1994. Monokine antagonism is reduced in patients with IDDM. Diabetes 43:1242-1247.
58. Mandrup-Poulsen, T., U. Zumsteg, J. I. Reimers, F. Pociot, I. Morch, S. Helqvist, C. A. Dinarello, and J. Nerup. 1993. Involvement of interleukin-1 and interleukin-1 antagonism in pancreatic-β cell destruction in insulin-dependent diabetes mellitus. Cytokine 5:185-191.
59. Manetti, R., P. Parronchi, M.-G. Giudizi, M.-P. Piccinni, E. Maggi, G. Trinchieri, and S. Romagnani. 1989. Natural killer cell stimulatory factor (interleukin 12) induces T helper type (Th1)-specific immune responses and inhibits the development of IL-4 producing Th cells. J. Exp. Med. 177:1199-1204.
60. Martin, S., T. Hibino, A. Faust, R. Kleeman, and H. Kolb. 1996. Differential expression of ICAM-1 and LFA-1 versus L-selectin and VCAM-1 in autoimmune insulitis of NOD mice and association with both Th1 and Th2-type infiltrates. J. Autoimmun. 9:637-643.
61. McFarland, H. F. 1996. Complexities in the treatment of autoimmune disease. Science 274:2037-2038.
62. Mizutani, H., L. T. May, P. B. Sehgal, and T. S. Kupper. 1989. Synergistic interactions of IL-1 and IL-6 in T cell activation. J. Immunol. 143:896-901.
63. Moritani, M., K. Yoshimoto, F. Tashiro, C. Hashimoto, J. Miyazaki, S. Ii, E. Kudo, H. Iwahana, Y. Hayashi, T. Sano, and M. Itakura. 1994. Transgenic expression of IL-10 in pancreatic islet cells accelerates autoimmune insulin's and diabetes in non-obese diabetic mice. Int. Immunol. 6:1927-1936.
64. Mosmann, T. R., H. Chervinshi, M. W. Bond, M. A. Giedlin, and R. L. Coffman. 1986. Two types of murine helper T-cell clones. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136:2348-2357.
65. Mosmann, T. R., and R. L. Coffman. 1989. Th1 and Th2 cells. Different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145-1173.
66. Mueller, R., J. D. Davies, T. Krahl, and N. Sarvetnick. 1997. IL-4 expression by grafts from transgenic mice fails to prevent allograft rejection. J. Immunol. 159:1599-1603.
67. Mueller, R., T. Krahl, and N. Sarvetnick. 1997. Tissue-specific expression of interleukin-4 induces extracellular matrix accumulation and extravasation of B cells. Lab. Investig. 76:117-128.
68. Pakala, S. V., M. D. Kurrer, and J. D. Katz. 1997. T helper 2 (Th2) T cells induce acute pancreatis and diabetes in immune-compromised nonobese diabetic (NOD) mice. J. Exp. Med. 186:299-306.
69. Pawson, T. 1995. Protein modules and signaling networks. Nature 373:573-580.
70. Pennline, K. J., E. Roque-Gaffney, and M. Monahan. 1994. Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse. Clin. Immunol. Immunopathol. 71:169-175.
71. Radvanyi, L. G., Y. Shi, H. Vaziri, A. Sharma, R. Dhala, G. Mills, and R. Miller. 1996. CD28 costimulation inhibits TCR-induced apoptosis during a primary T cell response. J. Immunol. 156:1788-1798.
72. Rappoport, M. J., A. Jaramillo, D. Zipris, A. H. Lazarus, D. V. Serreze, E. H. Leiter, P. Cyopick, J. S. Danska, and T. L. Delovitch. 1993. Interleukin 4 reverses T cell unresponsiveness and prevents the onset of diabetes in non-obese diabetic mice. J. Exp. Med. 178:87-97.
73. Robinson, N., and J. H. Fuller. 1985. Role of life events and difficulties in the onset of diabetes mellitus. J. Psychosom. Res. 29:583-591.
74. Romagnani, S. 1995. Biology of human Th1 and Th2 cells. J. Clin. Immunol. 15:121-129.
75. Rousset, F., E. Garcia, T. Defrance, C. Peronne, N. Vezzio, D.-H. Hsu, R. Kastelein, K. W. Moore, and J. Banchereau. 1992. Interleukin-10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc. Natl. Acad. Sci. USA 89:1890-1893.
76. Sad, S., and T. R. Mosmann. 1994. Single IL-2 secreting precursor CD4 T cell can develop into either Th1 or Th2 cytokine secretion phenotype. J. Immunol. 153:3514-3522.
77. Samuelsson, U., C. Johansson, and J. Ludvigsson. 1993. Breast-feeding seems to play a marginal role in the prevention of IDDM. Diabetes Res. Clin. Pract. 19:203-210.
78. Santamaria, P., E. Nakhleh, D. Sutherland, and J. E. L. Barbosa. 1991. Characterization of T lymphocytes infiltrating human pancreas allograft affected by isletitis and recurrent diabetes. Diabetes 41:53-61.
79. Sarvetnick, N., J. Shizuru, D. Liggitt, L. Martin, B. McIntyre, A. Gregory, T. Parslow, and T. Stewart. 1990. Loss of pancreatic islet tolerance induced by β-cell expression of interferon-γ. Nature 346:844-847.
80. Shimada, A., B. Charlton, P. Rohane, C. Taylor-Edwards, and C. G. Fathman. 1996. Immune regulation in type 1 diabetes. J. Autoimmun. 9:263-269.
81. Shimada, A., B. Charlton, C. Taylor-Edwards, and C. G. Fathman. 1996. Beta-cell destruction may be a late consequence of the autoimmune process in nonobese diabetic mice. Diabetes 45:1063-1067.
82. Stewart, T. A., B. Hultgren, X. Huang, S. Pitts-Meek, J. Hully, and N. J. MacLachlan. Induction of type I diabetes by interferon-γ in transgenic mice Science 260:1942-1946.
83. Swain, S. L. 1993. IL-4 dictates T-cell differentiation. Res. Immunol. 144: 616-620.
84. Swain, S. L., A. D. Weinberg, M. English, and G. Houston. 1990. IL-4 directs the development of Th2-like helper functions. J. Immunol. 145:3796-3806.
85. Tanaka, T., J. Hu-Li, R. A. Seder, B. Groth, and W. E. Paul. 1993. Interleukin 4 suppresses interleukin 2 and interferon-γ production by naive T cells stimulated by accessory cell-dependent receptor engagement. Proc Natl. Acad. Sci. USA 90:5914-5918.
86. Thorsby, E., and K. S. Ronningen. 1993. Particular HLA-DQ molecules play a dominant role in determining susceptibility or resistance to type I (insulin dependent) diabetes mellitus. Diabetologia 36:371-377.
87. Tian, J., P. V. Lehmann, and D. L. Kaufman. 1997, Determinant spreading of T helper cell 2 (Th2) responses to pancreatic islet autoantigens. J. Exp. Med. 186:2039-2043.
88. Tivol, E. A., N. A. Schweitzer, and A. H. Sharpe. 1996. Costimulation and autoimmunity. Curr. Opin. Immunol. 8:822-830.
89. Tomer, Y., G. Barbesion, D. Greenberg, and T. F. Davies. 1997. The immunogenetics of autoimmune diabetes and autoimmune thyroid disease. Trends Endocrinol. Metab. 8:63-70.
90. Tominaga, Y., M. Nagata, H. Yasuda, N. Okamoto, K. Arisawa, H. Moriyama, M. Miki, K. Yokono, and M. Kasuga. 1998. Administration of IL-4 prevents autoimmune diabetes but enhances pancreatic insulitis in NOD mice. Clin. Immunol. Immunopathol. 86:209-218.
91. Trembleau, S., G. Penna, S. Gregori, M. K. Gately, and L. Adorini. 1997. Deviation of pancreas-infiltrating cells to Th2 by interleukin-12 antagonist administration inhibits autoimmune diabetes. Eur. J. Immunol. 27:2330-2339.
92. Wogensen, L., X. Huang, and N. Sarvetnick. 1993. Leukocyte extravasation into the pancreatic tissue in transgenic mice expressing IL-10 in the islets of Langerhans. J. Exp. Med. 178:175-185.
93. Wogensen, L., M.-S. Lee, and N. Sarvetnick. 1994. Production of interleukin 10 by islet cells accelerates immune-mediated destruction of β cells in non-obese diabetic mice. J. Exp. Med. 179:1379-1384.